|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:359–386. 2015.
View Article : Google Scholar
|
|
2
|
Roobol MJ, Steyerberg EW, Kranse R,
Wolters T, van den Bergh RC, Bangma CH and Schröder FH: A
risk-based strategy improves prostatespecific antigen-driven
detection of prostate cancer. Eur Urol. 57:79–85. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bussemakers MJ, van Bokhoven A, Verhaegh
GW, Smit FP, Karthaus HF, Schalken JA, Debruyne FM, Ru N and Isaacs
WB: DD3: A new prostate-specific gene, highly overexpressed in
prostate cancer. Cancer Res. 59:5975–5979. 1999.PubMed/NCBI
|
|
4
|
Tomlins SA, Rhodes DR, Perner S,
Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J,
Kuefer R, et al: Recurrent fusion of TMPRSS2 and ETS transcription
factor genes in prostate cancer. Science. 310:644–648. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Harden SV, Sanderson H, Goodman SN, Partin
AA, Walsh PC, Epstein JI and Sidransky D: Quantitative GSTP1
methylation and the detection of prostate adenocarcinoma in sextant
biopsies. J Natl Cancer Inst. 95:1634–1637. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ilic D, Neuberger MM, Djulbegovic M and
Dahm P: Screening for prostate cancer. Cochrane Database Syst Rev.
CD0047202013.PubMed/NCBI
|
|
7
|
Wang Y, Wu N, Pang B, Tong D, Sun D, Sun
H, Zhang C, Sun W, Meng X, Bai J, et al: TRIB1 promotes colorectal
cancer cell migration and invasion through activation MMP-2 via
FAK/Src and ERK pathways. Oncotarget. 8:47931–47942.
2017.PubMed/NCBI
|
|
8
|
Yoshida A, Kato JY, Nakamae I and
Yoneda-Kato N: COP1 targets C/EBPα for degradation and induces
acute myeloid leukemia via Trib1. Blood. 122:1750–1760. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ye Y, Wang G, Wang G, Zhuang J, He S, Song
Y, Ni J, Xia W and Wang J: The oncogenic role of tribbles 1 in
hepatocellular carcinoma is mediated by a feedback loop involving
microRNA-23a and p53. Front Physiol. 8:7892017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
García-Perdomo HA, Chaves MJ, Osorio JC
and Sanchez A: Association between TMPRSS2:ERG fusion gene and the
prostate cancer: Systematic review and meta-analysis. Cent European
J Urol. 71:410–419. 2018.PubMed/NCBI
|
|
11
|
Edgar R, Domrachev M and Lash AE: Gene
expression omnibus: NCBI gene expression and hybridization array
data repository. Nucleic Acids Res. 30:207–210. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Varambally S, Yu J, Laxman B, Rhodes DR,
Mehra R, Tomlins SA, Shah RB, Chandran U, Monzon FA, Becich MJ, et
al: Integrative genomic and proteomic analysis of prostate cancer
reveals signatures of metastatic progression. Cancer Cell.
8:393–406. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu YP, Landsittel D, Jing L, Nelson J, Ren
B, Liu L, McDonald C, Thomas R, Dhir R, Finkelstein S, et al: Gene
expression alterations in prostate cancer predicting tumor
aggression and preceding development of malignancy. J Clin Oncol.
22:2790–2799. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang DW, Sherman BT, Tan Q, Collins JR,
Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC and Lempicki
RA: The DAVID gene functional classification tool: A novel
biological module-centric algorithm to functionally analyze large
gene lists. Genome Biol. 8:R1832007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kanehisa M: The KEGG database. Novartis
Found Symp. 247:91-103, 119–128, 244–252. 2002.
|
|
17
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The gene
ontology consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: New features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bandettini WP, Kellman P, Mancini C,
Booker OJ, Vasu S, Leung SW, Wilson JR, Shanbhag SM, Chen MY and
Arai AE: MultiContrast delayed enhancement (MCODE) improves
detection of subendocardial myocardial infarction by late
gadolinium enhancement cardiovascular magnetic resonance: A
clinical validation study. J Cardiovasc Magn Reson. 14:832012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kent WJ, Sugnet CW, Furey TS, Roskin KM,
Pringle TH, Zahler AM and Haussler D: The human genome browser at
UCSC. Genome Res. 12:996–1006. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen X, Cheung ST, So S, Fan ST, Barry C,
Higgins J, Lai KM, Ji J, Dudoit S, Ng IO, et al: Gene expression
patterns in human liver cancers. Mol Biol Cell. 13:1929–1939. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Roessler S, Jia HL, Budhu A, Forgues M, Ye
QH, Lee JS, Thorgeirsson SS, Sun Z, Tang ZY, Qin LX and Wang XW: A
unique metastasis gene signature enables prediction of tumor
relapse in early-stage hepatocellular carcinoma patients. Cancer
Res. 70:10202–10212. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wurmbach E, Chen YB, Khitrov G, Zhang W,
Roayaie S, Schwartz M, Fiel I, Thung S, Mazzaferro V, Bruix J, et
al: Genome-wide molecular profiles of HCV-induced dysplasia and
hepatocellular carcinoma. Hepatology. 45:938–947. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao H, Li J, Li X, Han C, Zhang Y, Zheng
L and Guo M: Silencing GPX3 expression promotes tumor metastasis in
human thyroid cancer. Curr Protein Pept Sci. 16:316–321. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cao S, Yan B, Lu Y, Zhang G, Li J, Zhai W,
Guo W and Zhang S: Methylation of promoter and expression silencing
of GPX3 gene in hepatocellular carcinoma tissue. Clin Res Hepatol
Gastroenterol. 39:198–204. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yu YP, Yu G, Tseng G, Cieply K, Nelson J,
Defrances M, Zarnegar R, Michalopoulos G and Luo JH: Glutathione
peroxidase 3, deleted or methylated in prostate cancer, suppresses
prostate cancer growth and metastasis. Cancer Res. 67:8043–8050.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Edelman GM and Crossin KL: Cell adhesion
molecules: Implications for a molecular histology. Annu Rev
Biochem. 60:155–190. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fang E, Zhang X, Wang Q and Wang D:
Identification of prostate cancer hub genes and therapeutic agents
using bioinformatics approach. Cancer Biomark. 20:553–561. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang Y, Zhang X, Song D and Wei J: Piwil2
modulates the invasion and metastasis of prostate cancer by
regulating the expression of matrix meta lloproteinase-9 and
epithelial-mesenchymal transitions. Oncol Lett. 10:1735–1740. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gaudet S, Branton D and Lue RA:
Characterization of PDZ binding kinase, a mitotic kinase. Proc Natl
Acad Sci USA. 97:5167–5172. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Abe Y, Matsumoto S, Kito K and Ueda N:
Cloning and expression of a novel MAPKK-like protein kinase,
lymphokine-activated killer T-cell-originated protein kinase,
specifically expressed in the testis and activated lymphoid cells.
J Biol Chem. 275:21525–21531. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang C, Habets G and Bollag G:
Interrogating the kinome. Nat Biotechnol. 29:981–983. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lu Y, Muller M, Smith D, Dutta B, Komurov
K, Iadevaia S, Ruths D, Tseng JT, Yu S, Yu Q, et al: Kinome
siRNA-phosphoproteomic screen identifies networks regulating AKT
signaling. Oncogene. 30:4567–4577. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Matsumoto S, Abe Y, Fujibuchi T, Takeuchi
T, Kito K, Ueda N, Shigemoto K and Gyo K: Characterization of a
MAPKK-like protein kinase TOPK. Biochem Biophys Res Commun.
325:997–1004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Park JH, Nishidate T, Nakamura Y and
Katagiri T: Critical roles of T-LAK cell-originated protein kinase
in cytokinesis. Cancer Sci. 101:403–411. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fujibuchi T, Abe Y, Takeuchi T, Ueda N,
Shigemoto K, Yamamoto H and Kito K: Expression and phosphorylation
of TOPK during spermatogenesis. Dev Growth Differ. 47:637–644.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Park JH, Lin ML, Nishidate T, Nakamura Y
and Katagiri T: PDZ-binding kinase/T-LAK cell-originated protein
kinase, a putative cancer/testis antigen with an oncogenic activity
in breast cancer. Cancer Res. 66:9186–9195. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Singh PK, Srivastava AK, Dalela D, Rath
SK, Goel MM and Bhatt ML: Expression of PDZ-binding kinase/T-LAK
cell-originated protein kinase (PBK/TOPK) in human urinary bladder
transitional cell carcinoma. Immunobiology. 219:469–474. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kim DJ, Li Y, Reddy K, Lee MH, Kim MO, Cho
YY, Lee SY, Kim JE, Bode AM and Dong Z: Novel TOPK inhibitor
HI-TOPK-032 effectively suppresses colon cancer growth. Cancer Res.
72:3060–3068. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sun H, Zhang L, Shi C, Hu P, Yan W, Wang
Z, Duan Q, Lu F, Qin L, Lu T, et al: TOPK is highly expressed in
circulating tumor cells, enabling metastasis of prostate cancer.
Oncotarget. 6:12392–12404. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen JH, Fang SM and Liang YK: Expression
and clinical significance of PBK in prostate cancer tissues.
Guangzhou Pharm. 48:1000–8535. 2017.
|
|
44
|
Simons-Evelyn M, Bailey-Dell K, Toretsky
JA, Ross DD, Fenton R, Kalvakolanu D and Rapoport AP: PBK/TOPK is a
novel mitotic kinase which isupregulated in burkitt's lymphoma and
other highly proliferative malignant cells. Blood Cells Mol Dis.
27:825–829. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Simons-Evelyn M, Bailey-Dell K, Toretsky
JA, Ross DD, Fenton R, Kalvakolanu D and Rapoport AP: PBK/TOPK is a
novel mitotic kinase which is upregulated in Burkitt's lymphoma and
other highly proliferative malignant cells. Blood Cells Mol Dis.
27:825–829. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wei D, Gong W, Kanai M, Schlunk C, Wang L,
Yao JC, Wu TT, Huang S and Xie K: Drastic down-regulation of
Krüppel-like factor 4 expression is critical in human gastric
cancer development and progression. Cancer Res. 65:2746–2754. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ohnishi S, Ohnami S, Laub F, Aoki K,
Suzuki K, Kanai Y, Haga K, Asaka M, Ramirez F and Yoshida T:
Downregulation and growth inhibitory effect of epithelial-type
Krüppel-like transcription factor KLF4, but not KLF5, in bladder
cancer. Biochem Biophys Res Commun. 308:251–256. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wei D, Kanai M, Jia Z, Le X and Xie K:
Kruppel-like factor 4 induces p27Kip1 expression in and suppresses
the growth and metastasis of human pancreatic cancer cells. Cancer
Res. 68:4631–4639. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Katz JP, Perreault N, Goldstein BG, Lee
CS, Labosky PA, Yang VW and Kaestner KH: The zinc-finger
transcription factor Klf4 is required for terminal differentiation
of goblet cells in the colon. Development. 129:2619–2628.
2002.PubMed/NCBI
|
|
50
|
Ghaleb AM, McConnell BB, Nandan MO, Katz
JP, Kaestner KH and Yang VW: Haploinsufficiency of Krüppel-like
factor 4 promotes adenomatous polyposis coli dependent intestinal
tumorigenesis. Cancer Res. 67:7147–7154. 2007. View Article : Google Scholar : PubMed/NCBI
|
